MeschkeL, McNeelyC, BrownK, PratherLM. Reproductive health knowledge, attitudes, and behaviors among women enrolled in medication-asssited treatment for opioid use disorder. J Womens Health (Larchmt), 2018; 27:1215–1224.
2.
AngelottaC, WeissCJ, AngelottaJW, FriedmanRA. A moral or medical problem? The relationship between legal penalties and treatment practices for opioid use disorders in pregnant women. Womens Health Issues, 2016; 26:595–601.
3.
OlsenA, BanwellC, DanceP. Internal or infernal devices: Experiences of contraception among Australian women living with hepatitis C. Health Care Women Int, 2009; 30:456–474.
4.
BlackKI, StephensC, HaberPS, LintzerisN. Unplanned pregnancy and contraceptive use in women attending drug treatment services. Aust N Z J Obstet Gynaecol, 2012; 52:146–150.
5.
LuckeJC, HallWD. Under what conditions is it ethical to offer incentives to encourage drug-using women to use long-acting forms of contraception?. Addiction, 2012; 107:1036–1041.
6.
OlsenA, BanwellC, MaddenA. Contraception, punishment and women who use drugs. BMC Women's Health, 2014; 14:5.
7.
HeilSH, HandDJ, SigmonSC, BadgerGJ, MeyerMC, HigginsST. Using behavioral economic theory to increase use of effective contraceptives among opioid-maintained women at risk of unintended pregnancy. Prev Med, 2016; 92:62–67.
8.
BlackK, DayCA. Improving access to long-acting contraceptive methods and reducing unplanned pregnancy among women with substance use disorders. Subst Abuse, 2016; 10(S1):27–33.
9.
TerplanM, HandDJ, HutchinsonM, Salisbury-AfsharE, HeilSH. Contraceptive use and method choice among women with opioid and other substance use disorders: A systematic review. Prev Med, 2015; 80:23–31.
10.
OlsenA. Sexual and reproductive health ‘choice’: Women living with contraception. Int J Public Health, 2007; 52:195–196.
